GlassScriptPhysician profile
Taral Navinchandra Patel
NPI 1730111642
$171,144.52
in general payments reported to CMS, 2019-2025
38 companies · $33K in 2025
The $33K reported for 2025 was more than what 95% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56K · 2020: $16K · 2021: $19K · 2022: $15K · 2023: $1,969 · 2024: $30K · 2025: $33K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $25K · Travel and Lodging: $8,015 · Food and Beverage: $6,922.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $25,383.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $25,000.00 |
| Travel and Lodging | $8,015.12 |
| Food and Beverage | $6,922.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $87,837.59 | 2019-2025 | General - Vascular Access, General - Balloons, General - Structural Heart |
| Abbott Laboratories | $35,515.57 | 2019-2025 | Coroflow, Absolute Pro, Dragonfly Opstar |
| Cardiovascular Systems INC. | $15,859.57 | 2019-2022 | |
| Angiodynamics, INC. | $12,858.14 | 2022-2025 | Alphavac, Angiovac |
| Teleflex LLC | $9,323.81 | 2019-2025 | Supercross, Guideliner |
| Arrow International, INC. | $2,015.45 | 2019 | |
| Abiomed | $1,151.05 | 2019-2025 | Impella |
| Shockwave Medical, INC | $1,116.50 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $812.84 | 2019-2023 | Xarelto |
| Asahi Intecc USA, INC. | $801.26 | 2019-2024 | Peripheral Vascular, Asahi Ptca Guide Wire |
| Amgen INC. | $560.92 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $458.46 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $361.29 | 2019-2024 | Lifevest |
| Inari Medical, INC. | $350.33 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $263.39 | 2019-2022 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $202.79 | 2019-2023 | |
| Emd Serono, INC. | $194.32 | 2019 | |
| Siemens Medical Solutions USA, INC. | $193.74 | 2022 | |
| Penumbra, INC. | $178.44 | 2021-2025 | Indigo System |
| Philips North America LLC | $171.57 | 2022-2024 | (P84) Igt Devices Systems |
| Amarin Pharma, INC. | $139.74 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $129.49 | 2019-2021 | |
| Astellas Pharma US INC | $117.88 | 2019-2022 | |
| Ekos Corporation | $100.91 | 2019 | |
| Pharmacosmos Therapeutics INC. | $99.85 | 2025 | Monoferric |
| Edwards Lifesciences Corporation | $88.26 | 2019 | |
| Asahi Intecc Co., LTD. | $60.47 | 2024 | Peripheral Vascular |
| Actelion Pharmaceuticals US, INC. | $33.99 | 2021 | |
| Acist Medical Systems, INC. | $18.91 | 2022 | |
| Cmp Pharma, INC. | $17.85 | 2022 | |
| Lundbeck LLC | $17.52 | 2019 | |
| B. Braun Interventional Systems INC. | $17.25 | 2025 | Nit-Occlud Pda |
| Esperion Therapeutics, INC. | $17.22 | 2022 | |
| Celonova Biosciences, INC. | $15.92 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.70 | 2022 | |
| Cardiva Medical, INC. | $15.67 | 2025 | Optowire |
| Sanofi-Aventis U.S. LLC | $10.86 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taral Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.